Posts by Sally
Outreach Initiative to Expand Access to Depot Medroxyprogesterone Acetate (DMPA)
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Read MoreWebinar Introduces Pharmacists to New Hormonal Contraceptives
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Read MoreWebinar Equips Pharmacists to Provide Contraception Care During COVID-19
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Read MorePutting Policy into Practice: Contraception Care in San Francisco Pharmacies
What makes some pharmacies more successful than others at implementing pharmacist-prescribed contraception care? To answer this question, we conducted a study to determine the extent of hormonal contraceptive prescribing, also referred to as furnishing in California, among San Francisco community pharmacies, and identify the factors that led to successful implementation.
Read MoreReducing Maternal Mortality in the United States through Collaboration
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Read MoreNew Webinar Prepares Pharmacists to Provide Reproductive Health Services and Referrals
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Read MoreMeet Phexxi – A New Non-Hormonal Contraceptive Gel
About the Product Lactic acid, citric acid, and potassium bitartrate (Phexxi, Evofem Biosciences) is a prescription combination, non-hormonal contraceptive gel approved by the FDA in May 2020. The vaginal gel…
Read MoreUpdates in Male Contraceptive Agents
Male contraceptive agents have been highly anticipated as the next step in contraception innovation. To date, several hormonal agents have been developed and tested for safety and efficacy, with three…
Read MoreClinical Considerations for Contraception During COVID: Extended Duration of IUDs and Implants
During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.
Read More5 Pearls from the 2020 States Forum on Pharmacist Birth Control Services
The second annual States Forum on Pharmacist Birth Control Services recently was held by the Birth Control Pharmacist project in partnership with the National Alliance of State Pharmacy Associations (NASPA).…
Read More